Skip to Content

Sopharma Trading AD SFT

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SFT is trading at a 22% discount.
Price
BGN 5.52
Fair Value
BGN 8.18
Uncertainty
High
1-Star Price
BGN 8.82
5-Star Price
BGN 1.47
Economic Moat
Bzwc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SFT is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
19.43
Price/Sales
0.12
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Small Value
Total Number of Employees
2,608

Comparables

Valuation

Metric
SFT
SALR
SFA
Price/Earnings (Normalized)
19.4321.069.44
Price/Book Value
1.612.771.33
Price/Sales
0.120.360.45
Price/Cash Flow
5.0214.4919.06
Price/Earnings
SFT
SALR
SFA

Financial Strength

Metric
SFT
SALR
SFA
Quick Ratio
0.610.800.74
Current Ratio
1.111.301.29
Interest Coverage
2.7017.3110.57
Quick Ratio
SFT
SALR
SFA

Profitability

Metric
SFT
SALR
SFA
Return on Assets (Normalized)
4.06%5.20%7.10%
Return on Equity (Normalized)
22.57%14.02%13.81%
Return on Invested Capital (Normalized)
8.34%10.94%9.78%
Return on Assets
SFT
SALR
SFA
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpVlgkfylmpRpmfjt$69.9 Bil
COR
Cencora IncNdfbscmysYvmgwz$47.4 Bil
CAH
Cardinal Health IncFbphghjgWbrtglt$25.2 Bil
SHTDY
Sinopharm Group Co Ltd ADRYzdvbd$8.6 Bil
SHTDF
Sinopharm Group Co LtdKndswq$8.6 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HLdvphs$8.2 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HKcxjlrs$8.1 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoSqkjvch$7.7 Bil
MAHLY
Medipal Holdings Corp ADRNvw$3.3 Bil
MEPDF
Medipal Holdings CorpMnnbd$3.3 Bil

Sponsor Center